OverviewSuggest Edit

Inogen is a manufacturer and an accredited homecare provider dedicated to oxygen therapy. Its mission is to improve freedom and independence for oxygen therapy patients through innovative products and services. The Company's compact, lightweight and travel-approved portable oxygen concentrators are designed to free patients from heavy tanks, managing tank refills or being tethered to stationary systems. As a manufacturer and Accredited Homecare Provider dedicated to oxygen therapy, Inogen is ideally suited to develop products tailored to oxygen therapy users and to provide superior service to those users in their homes. 

TypePublic
Founded2001
HQGoleta, CA, US
Websiteinogen.com
Employee Ratings2.9
Overall CultureB-

Latest Updates

Employees (est.) (Dec 2019)1,020(-7%)
Job Openings97
Revenue (FY, 2020)$308.5 M(-14%)
Share Price (Dec 2021)$34(+2%)
Cybersecurity ratingDMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Inogen

Scott Wilkinson

Scott Wilkinson

President, CEO and Director
Alison Bauerlein

Alison Bauerlein

Founder, CFO and Executive Vice President, Finance
Bart Sanford

Bart Sanford

Executive Vice President, Operations
Scott Beardsley

Scott Beardsley

Director
George Parr

George Parr

CCO
Stanislav Glezer

Stanislav Glezer

Chief Medical Officer
Show more

Inogen Office Locations

Inogen has offices in Goleta, Aurora, Austin, Cleveland and in 7 other locations
Goleta, CA, US (HQ)
301 Coromar Dr
Aurora, CO, US
Aurora, CO, USA
Austin, TX, US
Austin, TX, USA
Cleveland, OH, US
Cleveland, OH, USA
Dallas, TX, US
Dallas, TX, USA
Denver, CO, US
Denver, CO, USA
Show all (12)

Inogen Financials and Metrics

Inogen Revenue

Embed Graph
View revenue for all periods
Inogen's revenue was reported to be $308.49 m in FY, 2020
USD

Revenue (Q1, 2021)

86.9m

Gross profit (Q1, 2021)

44.3m

Gross profit margin (Q1, 2021), %

51%

Net income (Q1, 2021)

(732.0k)

EBIT (Q1, 2021)

(2.1m)

Market capitalization (31-Dec-2021)

759.0m

Closing stock price (31-Dec-2021)

34.0

Cash (31-Mar-2021)

220.0m

EV

557.9m
Inogen's current market capitalization is $759 m.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

73.1m113.6m168.2m225.5m358.1m361.9m308.5m

Revenue growth, %

41%28%

Cost of goods sold

38.7m61.6m85.2m110.2m164.0m176.0m156.8m

Gross profit

34.4m52.1m83.0m115.3m194.1m186.0m151.7m
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Cash

56.8m66.1m92.9m143.0m196.6m198.0m212.0m

Accounts Receivable

30.8m31.4m37.0m34.3m29.7m

Prepaid Expenses

2.6m7.1m10.2m17.9m

Inventories

1.1m870.0k1.7m18.8m27.1m35.7m24.8m
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Net Income

6.8m11.6m20.5m21.0m51.8m21.0m(5.8m)

Depreciation and Amortization

12.1m14.0m13.6m12.3m11.3m13.8m18.6m

Inventories

(3.6m)(2.6m)(7.5m)(5.9m)(10.0m)(10.3m)7.6m

Accounts Payable

3.6m1.6m(86.0k)7.4m6.4m3.2m(5.8m)
USDQ1, 2014

Debt/Equity

0.1 x

Debt/Assets

0.1 x

Financial Leverage

1.3 x
Show all financial metrics

Inogen Cybersecurity Score

Cybersecurity ratingPremium dataset

D

67/100

SecurityScorecard logo

Inogen Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

CSRHub logo

Inogen Online and Social Media Presence

Embed Graph

Inogen Company Culture

  • Overall Culture

    B-

    78/100

  • CEO Rating

    A

    83/100

  • Compensation

    C+

    74/100

Learn more on Comparably

Inogen News and Updates

Inogen (INGN) Shareholder Litigation Alert: Should Inogen Management be Held Accountable for Investors Losses? Contact Johnson Fistel, LLP Regarding Pending Derivative Case

SAN DIEGO, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP, the court-appointed Lead Counsel in a derivative action brought for the benefit of Inogen, Inc. (NASDAQ: INGN) and its shareholders, announces today that a securities fraud class action pending before U.S. District Judge Fernando …

Global Portable Oxygen Concentrator Market (2020 to 2025) - Players Include Inogen, O2 Concepts and Precision Medical

Dublin, Nov. 30, 2020 (GLOBE NEWSWIRE) -- The "Portable Oxygen Concentrator Global Market Insights 2020, Analysis and Forecast to 2025, by Manufacturers, Regions, Technology, Application" report has been added to ResearchAndMarkets.com's offering. This report describes the global market size of …

Moore Kuehn, PLLC Announces Investigations of AAC Holdings (NYSE: AAC), American Renal Associates Holdings (NYSE: ARA), Teledoc Health (NYSE: TDOC), and Inogen (NASDAQ: INGN)

NEW YORK, Sept. 19, 2019 /PRNewswire/ -- Moore Kuehn, PLLC, a securities law firm located on Wall Street in downtown New York City, is investigating potential claims involving the directors and officers regarding possible breaches of fiduciary duties and other violations of law related to...

Park Hotels & Resorts Set to Join S&P MidCap 400; Inogen to Join S&P SmallCap 600

NEW YORK, Sept. 12, 2019 /PRNewswire/ -- Park Hotels & Resorts Inc. (NYSE: PK) will replace Inogen Inc. (NASD: INGN) in the S&P MidCap 400 and Inogen will replace Chesapeake Lodging Trust (NYSE: CHSP) in the S&P SmallCap 600 effective prior to the open of trading on Wednesday, September.…

Inogen stock drops 20% after earnings miss, cut outlook

Inogen Inc. shares dropped in the extended session Tuesday after the maker of oxygen therapy systems missed Wall Street earnings targets and cut its outlook for the year. Inogen shares, which had been briefly halted, dropped 20% after hours, following a 4.2% decline to close the regular session at …

INGN MAY 6th DEADLINE ALERT: Rosen Law Firm Reminds Inogen, Inc. Investors of Important Deadline in Securities Class Action Lawsuit- INGN

NEW YORK, April 19, 2019 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Inogen, Inc. from November 8, 2017 through February 26, 2019, inclusive (the "Class Period") of the important May 6, 2019 lead plaintiff deadline in the...
Show more

Inogen Frequently Asked Questions

  • When was Inogen founded?

    Inogen was founded in 2001.

  • Who are Inogen key executives?

    Inogen's key executives are Scott Wilkinson, Alison Bauerlein and Bart Sanford.

  • How many employees does Inogen have?

    Inogen has 1,020 employees.

  • What is Inogen revenue?

    Latest Inogen annual revenue is $308.5 m.

  • What is Inogen revenue per employee?

    Latest Inogen revenue per employee is $302.4 k.

  • Who are Inogen competitors?

    Competitors of Inogen include AuST, INTEGRA Biosciences and EarLens.

  • Where is Inogen headquarters?

    Inogen headquarters is located at 301 Coromar Dr, Goleta.

  • Where are Inogen offices?

    Inogen has offices in Goleta, Aurora, Austin, Cleveland and in 7 other locations.

  • How many offices does Inogen have?

    Inogen has 12 offices.